AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Part One: The Question of MRD in CLL Therapy
The HemOnc Pulse
Optimizing Treatment Strategies for Young CLL Patients
This chapter examines the decision-making process for referring a younger CLL patient to cell therapy after failing a BTK inhibitor and showing chemo sensitivity, focusing on CAR-T therapy and MRD monitoring. The discussion evaluates different clinical trials, emphasizing the impact of hazard ratios on treatment decisions and addressing challenges unique to CLL, such as Richter's transformation and immune reconstitution.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode